In a lab experiment, researchers found FBL-03G was effective at killing both local and metastatic pancreatic cancer cells. The findings were published in the journal Frontiers on Oncology in July 2019.

{{cta(‘90438494-6bd0-4c05-aee6-ee36a536f0d4’)}}

“The most significant conclusion is that tumor-targeted delivery of flavonoids, derived from cannabis, enabled both local and metastatic tumor cell kill, significant increasing survival from pancreatic cancer,” Assistant Professor Wilfred Ngwa, PhD told Yahoo Lifestyle. “This has major significance, given that pancreatic cancer is particularly refractory to current therapies.”

Pancreatic cancer makes up approximately 3% of all cancer diagnosed in the U.S. It has a five-year survival rate of 9% and is predicted to be the third-leading cause of cancer-related death by 2020.

Aphria Inc. Files Preliminary Base Shelf Prospectus

Risk of Prosecution for Marijuana-Related Companies. If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution. The Department of Treasury recently issued guidance noting: “[T]he Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana. Many states impose and enforce similar prohibitions. Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”